Neoplasia/BPH

conid:2531
-kaloNeDinamik-------------------------------------------jo
-session-------------------------------------------Array
(
    [ID_S] => IP: 44.192.52.167; DATE: 2022/11/27/ 02:33:35
    [tip] => 2
    [contentType] => db
    [ses_userid] => 2
    [thisMode] => 
    [level_0] => 2
    [level_1] => 9
    [level_2] => 6
    [level_3] => 0
    [level_4] => 0
    [level] => 2
    [nodetype] => 2
    [node_family_id] => 0
    [monitor] => content
    [id_contentit_from_php_file] => 2531
    [uniqueid] => 2022112702333544192521674646
    [lang] => Lng2
    [contentId] => 2531
    [browser] => IE
    [clas_css] => 0
    [level_p] => 2
    [lng] => Lng2
    [nodetype_ci] => -1
    [usr] => 0
    [vazhdopunen] => po
    [search_for] => ("urogenital neoplasms"[Majr] OR "prostatic hyperplasia"[majr] OR "bph"[ti] OR "luts"[ti] OR (("neoplasm"[ti] OR "neoplasms"[ti] OR "cancer"[ti] OR carcinoma[ti] OR adenocarcinoma[ti] OR tumor[ti] OR tumour[ti] OR tumors[ti] OR tumours[ti])  AND (bladder[ti] OR kidney[ti] OR renal[ti] OR prostate[ti] OR prostatic[ti] OR testis[ti] OR testicular[ti])) AND ("practice guideline" OR systematic[sb] OR "clinical trials"[mesh] OR "meta analysis"[pt] OR "epidemiologic studies"[mesh] OR randomi* OR "meta analysis" OR "evidence based" OR placebo* OR "single blind" OR "double blind" OR "control group" OR "triple blind" OR study[ti] OR studies[ti] OR trial[ti] OR trials[ti] OR consensus OR placebo OR review[pt] OR "sensitivity and specificity"[MeSH Terms] OR diagnos*[Ti] OR diagnosis[MeSH:noexp] OR diagnostic *[MeSH:noexp] OR diagnosis,differential[MeSH:noexp] OR diagnosis[Subheading:noexp] OR accuracy[Title/Abstract] OR "predictive value"[Title/Abstract]) AND (english[language] OR german[language] OR french[language] OR italian[language] OR spanish[language])  NOT veterinary[subheading] NOT "genital neoplasms, female"[mesh]
)

Neoplasia/BPH

medline.ch

En | De

Impressum | Feedback

No articles selected!

View Cart

You are here: Urology-Nephrology » Neoplasia/BPH

27. November 2022

Cardiovascular Diseases

Musculoskeletal Diseases

Inflammation-Infection

Zoom:

Page 1 of 7901


	Articles 1 - 20 / 158016

	Immediate radiotherapy versus observation in patients with node-positive prostate cancer after radical prostatectomy. Prostate Cancer Prostatic Dis Schaufler C, Kaul S, Fleishman A, Korets R, Chang P, Wagner A, Kim S, Bellmunt J, Kaplan I, Olumi AF, Gershman B. PMID: 36434164 [PubMed - as supplied by publisher]
	Germline mutations in prostate cancer: a systematic review of the evidence for personalized medicine. Prostate Cancer Prostatic Dis Marino F, Totaro A, Gandi C, Bientinesi R, Moretto S, Gavi F, Pierconti F, Iacovelli R, Bassi P, Sacco E. PMID: 36434163 [PubMed - as supplied by publisher]
	Differential operation of MLH1/MSH2 and FANCD2 crosstalk in chemotolerant bladder carcinoma: a clinical and therapeutic intervening study. Mol Cell Biochem Basu M, Mukhopadhyay D, Chakraborty B, Ghosh S, Pal DK, Ghosh A, Panda CK. PMID: 36434146 [PubMed - as supplied by publisher]
	Special Issue "Prostate Cancer: Recent Advances in Diagnostics and Treatment Planning". J Clin Med Tokas T. PMID: 36431300 [PubMed - as supplied by publisher]
	Utility of a Molecular Signature for Predicting Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer Patients: Comparison with the EORTC, CUETO and 2021 EAU Risk Groups. Int J Mol Sci Piao XM, Kim SK, Byun YJ, Zheng CM, Kang HW, Kim WT, Kim YJ, Lee SC, Kim WJ, Moon SK, Choi YH, Yun SJ. PMID: 36430959 [PubMed - as supplied by publisher]
	Lectin-Based Study Reveals the Presence of Disease-Relevant Glycoepitopes in Bladder Cancer Cells and Ectosomes. Int J Mol Sci Surman M, Wilczak M, Przyby. PMID: 36430846 [PubMed - as supplied by publisher]
	Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets. Int J Mol Sci di Meo NA, Lasorsa F, Rutigliano M, Loizzo D, Ferro M, Stella A, Bizzoca C, Vincenti L, Pandolfo SD, Autorino R, Crocetto F, Montanari E, Spilotros M, Battaglia M, Ditonno P, Lucarelli G. PMID: 36430837 [PubMed - as supplied by publisher]
	TERT Promoter Mutations as Simple and Non-Invasive Urinary Biomarkers for the Detection of Urothelial Bladder Cancer in a High-Risk Region. Int J Mol Sci Pakmanesh H, Anvari O, Forey N, Weiderpass E, Malekpourafshar R, Iranpour M, Shahesmaeili A, Ahmadi N, Bazrafshan A, Zendehdel K, Kannengiesser C, Ba I, McKay J, Zvereva M, Hosen MI, Sheikh M, Calvez-Kelm FL. PMID: 36430798 [PubMed - as supplied by publisher]
	Complexities of Prostate Cancer. Int J Mol Sci Wasim S, Lee SY, Kim J. PMID: 36430730 [PubMed - as supplied by publisher]
	Immune Checkpoint Inhibitor (ICI) Genes and Aging in Clear Cell Renal Cell Carcinoma (ccRCC): Clinical and Genomic Study. Cells Al-Danakh A, Safi M, Alradhi M, Chen Q, Baldi S, Zhu X, Yang D. PMID: 36429070 [PubMed - as supplied by publisher]
	A Comparative Study of Deep Neural Networks for Real-Time Semantic Segmentation during the Transurethral Resection of Bladder Tumors. Diagnostics (Basel) Varnyú D, Szirmay-Kalos L. PMID: 36428909 [PubMed - as supplied by publisher]
	Current Developments in Cellular Therapy for Castration Resistant Prostate Cancer: A Systematic Review of Clinical Studies. Cancers (Basel) Steinbach C, Merchant A, Zaharie AT, Horak P, Marhold M, Krainer M. PMID: 36428811 [PubMed - as supplied by publisher]
	Can Pre-Operative Neutrophil-to-Lymphocyte Ratio (NLR) Help Predict Non-Metastatic Renal Carcinoma Recurrence after Nephrectomy? (UroCCR-61 Study). Cancers (Basel) Allenet C, Klein C, Rouget B, Margue G, Capon G, Alezra E, Blanc P, Estrade V, Bladou F, Robert G, Bernhard JC. PMID: 36428784 [PubMed - as supplied by publisher]
	PSMA PET for the Evaluation of Liver Metastases in Castration-Resistant Prostate Cancer Patients: A Multicenter Retrospective Study. Cancers (Basel) Mattoni S, Farolfi A, Formaggio F, Bruno G, Caroli P, Cerci JJ, Eiber M, Fendler WP, Golfieri R, Herrmann K, Matteucci F, Mosconi C, Paolani G, Santoro M, Strigari L, Nanni C, Castellucci P, Fanti S. PMID: 36428771 [PubMed - as supplied by publisher]
	The Prevalence of Lower Limb and Genital Lymphedema after Prostate Cancer Treatment: A Systematic Review. Cancers (Basel) Clinckaert A, Callens K, Cooreman A, Bijnens A, Moris L, Van Calster C, Geraerts I, Joniau S, Everaerts W. PMID: 36428759 [PubMed - as supplied by publisher]
	Serum C-reactive Protein Level Predicts Overall Survival for Clear Cell and Non-Clear Cell Renal Cell Carcinoma Treated with Ipilimumab plus Nivolumab. Cancers (Basel) Yano Y, Ohno T, Komura K, Fukuokaya W, Uchimoto T, Adachi T, Hirasawa Y, Hashimoto T, Yoshizawa A, Yamazaki S, Tokushige S, Nishimura K, Tsujino T, Nakamori K, Yamamoto S, Iwatani K, Urabe F, Mori K, Yanagisawa T, Tsuduki S, Takahara K, Inamoto T, Miki J, Kimura T, Ohno Y, Shiroki R, Azuma H. PMID: 36428750 [PubMed - as supplied by publisher]
	Does Time to Adjuvant Chemotherapy after Radical Cystectomy Affect Survival in Muscle Invasive Bladder Cancer? A Systematic Review. Cancers (Basel) Kronstedt S, Doppalapudi SK, Boyle J, Chua K, Jang TL, Cacciamani GE, Ghodoussipour S. PMID: 36428737 [PubMed - as supplied by publisher]
	Artificial Intelligence for Clinical Diagnosis and Treatment of Prostate Cancer. Cancers (Basel) Rabaan AA, Bakhrebah MA, AlSaihati H, Alhumaid S, Alsubki RA, Turkistani SA, Al-Abdulhadi S, Aldawood Y, Alsaleh AA, Alhashem YN, Almatouq JA, Alqatari AA, Alahmed HE, Sharbini DA, Alahmadi AF, Alsalman F, Alsayyah A, Mutair AA. PMID: 36428686 [PubMed - as supplied by publisher]
	Diagnostic and Prognostic Biomarkers in Renal Clear Cell Carcinoma. Biomedicines Weaver C, Bin Satter K, Richardson KP, Tran LKH, Tran PMH, Purohit S. PMID: 36428521 [PubMed - as supplied by publisher]
	Contemporary Clinical Definitions, Differential Diagnosis, and Novel Predictive Tools for Renal Cell Carcinoma. Biomedicines Novacescu D, Feciche BO, Cumpanas AA, Bardan R, Rusmir AV, Bitar YA, Barbos VI, Cut TG, Raica M, Latcu SC. PMID: 36428491 [PubMed - as supplied by publisher]

Articles 1 - 20 / 158016

Page 1 of 7901



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy